PIGS

protein-coding

phosphatidylinositol glycan anchor biosynthesis class S, the group of Glycosylphosphatidylinositol transamidase complex|Phosphatidylinositol glycan anchor biosynthesis

Gene summary

This gene encodes a protein that is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes an essential component of the multisubunit enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. [provided by RefSeq, Jul 2008]

MANE transcript

NM_033198.4

Inheritance

AR

ClinVar variants

P:16U:97B:35

Top phenotype

Developmental and epileptic encephalopathy 95

gnomAD constraint

pLI —, LoF o/e 0.47

Max pathogenic AF

—

Genomic locus

chr17:28,553,383-28,571,794

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~18.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

glycosylphosphatidylinositol biosynthesis defect 18DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0029140

Submitter: ClinGen

*PIGS* was first reported in relation to autosomal recessive developmental and epileptic encephalopathy 95 (MONDO:0029140) in 2018 (Nguyen TTM et al., PMID:30269814). This condition is caused by variants in the *PIGS* gene, which encodes an essential component of the multisubunit enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. [provided by RefSeq, Jul 2008]. 87 unique variants (e.g., synonymous, missense, in-frame indel, nonsense, frameshift) have been reported in humans by ClinVar; 13 of these variants are classified as pathogenic or likely pathogenic in ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Eleven variants that have been reported in 9 probands in 3 publications (Nguyen TTM et al., 2018, PMID:30269814; Efthymiou S et al., 2021, PMID:33410539; Zhang L et al., 2020, PMID:32612635), are included in this curation. This gene-disease relationship is also supported by the protein interactions of the protein; *PIGS*, with GPI8, GAA1, and *PIG‑T *to form a stable, multi-component enzyme complex essential for the biochemical process of GPI anchoring. (Ohishi K et al., 2001, PMID:11483512). In summary, there is definitive evidence to support this gene-disease relationship. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Congenital Disorder of Glycosylation GCEP on the meeting date May 21, 2025 (SOP Version 11).

glycosylphosphatidylinositol biosynthesis defect 18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0029140

Submitter: G2P

glycosylphosphatidylinositol biosynthesis defect 18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0029140

Submitter: Labcorp Genetics (formerly Invitae)

glycosylphosphatidylinositol biosynthesis defect 18MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0029140

Submitter: Ambry Genetics

glycosylphosphatidylinositol biosynthesis defect 18STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0029140

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Developmental and epileptic encephalopathy 95AR

Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic

Intervention: Neurologic

Rationale: Among other manifestations, individuals may have difficult-to-control seizures, and management with oral pyridoxine has been described as beneficial

Refs: 30269814; 33410539Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PIGS variants in ClinVar

5 Conditions Cataloged
Inborn genetic diseasesTotal: 76
not providedTotal: 50
not specifiedTotal: 29
Glycosylphosphatidylinositol biosynthesis defect 18Total: 20
PIGS-related disorderTotal: 18

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_033198.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
22
clinvar
23
missense
3
clinvar
2
clinvar
93
clinvar
10
clinvar
3
clinvar
111
nonsense
1
clinvar
3
clinvar
2
clinvar
6
start loss
0
frameshift
1
clinvar
3
clinvar
1
clinvar
5
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
3
Total61097323148

Highest pathogenic variant AF is 0.00002395308

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 43 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_033198.4RefSeqNP_149975.112MANE Select
ENST00000308360.8EnsemblENSP00000309430.712MANE Select
ENST00000268758.13EnsemblENSP00000268758.92Standard
ENST00000395346.6EnsemblENSP00000378755.211Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
  • Attachment of GPI anchor to uPAR
  • Post-translational modification: synthesis of GPI-anchored proteins
  • Post-translational protein modification
  • Metabolism of proteins

Biological Process

  • attachment of GPI anchor to protein

Molecular Function

  • GPI-anchor transamidase activity
  • protein binding

Cellular Component

  • endoplasmic reticulum membrane
  • membrane
  • GPI-anchor transamidase complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000308360
Coding exons
12
Length
18490
Individuals with no LoFs
125693
Homozygous LoFs
0
Heterozygous LoFs
55
Defined
125748
p
0.000219
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7802853250.8780.00001783564
Missense (PolyPhen)6591.7690.70831036
Synonymous0.1721331360.9810.000007621172
Loss of Function2.451225.30.4750.00000116303

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000140.00012rare
Ashkenazi Jewish0.000500.00050rare
East Asian0.000280.00027rare
Finnish0.000140.00014rare
European (Non-Finnish)0.000280.00028rare
South Asian0.0000650.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the GPI transamidase complex. Essential for transfer of GPI to proteins, particularly for formation of carbonyl intermediates. {ECO:0000269|PubMed:11483512}.;

Recessive Scores

pRec
0.122

Intolerance Scores

LoFtool
0.708
RVIS EVS
0.09
RVIS percentile EVS
60.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
E
Essential (gene trap)
H
Indispensability pred.
N
Indispensability score
0.421

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.